glp 1 masld GLP-1 Fatty Liver MASH Approval: What Patients Should Know The Emerging Role of Glucagon-Like
Description
It not only successfully regulates blood sugar levels [1] but also reduces the appetite and, thereby, the weight of patients [2], especially in individuals with obesity and type 2 diabetes mellitus (T2DM)
Jiayi Guo, [email protected]
This is a dangerous misunderstanding of the law
While dulaglutide is another weekly-dose option, Ozempic typically demonstrates superior overall weight-loss outcomes
2024;103(23):e38444
For people with T2D, a phase 2 trial with mazdutide (doses 3, 4.5 and 6 mg) has shown reduction in HbA1c (up to 1.7%) and up to 7.1% WL at 20 weeks (Table 3), while early phase trials for MASH are in progress [72]
